Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes

Diabetic Medicine

Volumn 31, Issue 7, 2014, Pages 847-853

  Elliott, J ^a   Jacques, R M ^b   Kruger, J ^b   Campbell, M J ^b   Amiel, S A ^c   Mansell, P ^d   Speight, J ^e   Brennan, A ^b   Heller, S R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; COST OF ILLNESS; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION;

EID: 84922653136     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12441     Document Type: Article

References (30)

1. Tu E, Twigg SM, Duflou J, Semsarian C. Causes of death in young Australians with type 1 diabetes: a review of coronial post-mortem examinations. Med J Aust 2008; 188: 699-702.
2. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR et al. The British Diabetic Association cohort study, II: cause-specific mortality in patient with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471.
3. Feltbower FG, Bodansky HJ, Patterson CC, Parslow RC, Stephenson CR, Reynolds C et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes. Diabetes Care 2008; 31: 922-926.
4. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006; 49: 298-305.
5. Patterson C, Dahlquist G, Harjutsalo V, Joner G, Feltbower RG, Svensson J et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007; 50: 2439-2442.
6. NHS Information Centre. NHS reference costs, 2010-2011. Available at: http://data.gov.uk/dataset/nhs-reference-costs-2010-11/resource/2e929335-bfe2-4257-b5d8-69bafad74821. Last accessed 8 October 2013.
7. Diabetes Control and Complications Trial Research Group. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 1995; 18: 1415-1427.
8. Stephenson J, Fuller J. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study. Diabetologia 1994; 37: 278-285.
9. Lebenthal Y, Shalitin S, Yackobovitch-Gavan M, Phillip M, Lazar L. Retrospective comparative analysis of metabolic control and early complications in familial and sporadic type 1 diabetes patients. J Diabetes Complications 2012; 26: 219-224.
10. Health and Social Care Information Centrea. National Diabetes Audit 2010-2011 - Report 2: Complications and mortality. Available at: http://www.hscic.gov.uk/searchcatalogue?productid=7331. Last accessed 8 October 2013.
11. Leese G, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W et al. Frequency of severe hypoglycaemia requiring emergency treatment in type 1 and type 2 diabetes. Diabetes Care 2003; 26: 1176-1180.
12. Farmer AJ, Brockbank KJ, Keech ML, England EJ, Deakin CD. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med 2012; 29: 1447-1450.
13. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746-752.
14. Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes. Diabetes Care 2012; 35: 1638-1642.
15. Mulhauser I, Jorgens V, Berger M, Graninger W, Gurtler W, Hornke L et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983; 25: 470-476.
16. Samann A, Muhlhauser I, Bender R, Hunger-Dathe W, Kloos C, Muller UA. Flexible intensive insulin therapy with type 1 diabetes and high risk severe hypoglycaemia and diabetic ketoacidosis. Diabetes Care 2006; 29: 2196-2199.
17. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
18. European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus, 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129256.pdf. Last accessed 8 October 2013.
19. DAFNE. Fact Sheet Six. [PU07.006, Version 7 - June 2012]. Available at: http://www.dafne.uk.com/uploads/135/documents/06_factsheetsix_12pt_18_06_12.pdf. Last accessed 8 October 2013.
20. Holmes-Walker DJ, Llewellyn AC, Farrell K. A transition care programme which improves diabetes control and reduces hospital admission rate in young adults with Type 1 diabetes aged 15-25 years. Diabet Med 2007; 24: 1001-1004.
21. Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults, March 2010. http://www.diabetologists-abcd.org.uk/JBDS_DKA_Management.pdf. Last accessed 8 October 2013.
22. Davies M, Dixon S, Currie CJ, Davis RE, Peters JR. Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial. Diabet Med 2001; 18: 301-307.
23. Cavan DA, Hamilton P, Everett J, Kerr D. Reducing hospital inpatient length of stay for patients with diabetes. Diabetic Med 2001; 18: 162-164.
24. Health and Social Care Information Centre. National Diabetes Audit 2010-2011 - Report into the data quality of diabetes structured education. Available at: http://www.hscic.gov.uk/searchcatalogue?productid=7331. Last accessed 8 October 2013.
25. Medical Research Council. Developing and evaluating complex interventions: new guidance 2008. Available at: http://www.mrc.ac.uk/complexinterventionsguidance. Last accessed 8 October 2013.
26. Ellis J, Naar-King S, Templin T, Frey M, Cunningham P, Sheidow A et al. Multisystem therapy for adolescents with poorly controlled type 1 diabetes. Diabetes Care 2008; 31: 1746-1747.
27. Pedersen-Bjergaard U, Pramming S, Thorteinsson B. Recall of severe hypoglycaemia and self-estimated awareness in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-240.
28. Hammer M, Lammert M, Mejias SM, Kem W, Frier BM. Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009; 12: 281-290.
29. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011; 14: 665-671.
30. Speight J, Amiel SA, Bradley C, Heller S, Oliver L, Roberts S et al. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes. Diabetes Res Clin Pract 2010; 89: 22-29.